Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies

The prognostic impact of p53 immunostaining in a large series of tumours from epithelial ovarian cancer patients in a two-centre study was analysed. The study population (n=476) comprised of a retrospective series of 188 patients (Dutch cohort) and a prospective series of 288 patients (Scottish coho...

Descripción completa

Detalles Bibliográficos
Autores principales: de Graeff, P, Hall, J, Crijns, A P G, de Bock, G H, Paul, J, Oien, K A, ten Hoor, K A, de Jong, S, Hollema, H, Bartlett, J M S, Brown, R, van der Zee, A G J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360689/
https://www.ncbi.nlm.nih.gov/pubmed/16880779
http://dx.doi.org/10.1038/sj.bjc.6603300

Ejemplares similares

Ejemplares similares